Principles for modelling dose-response for the risk assessment of chemicals

Health risks from exposure to low levels of ionizing radiation : BEIR VII, Phase 2
I whakaputaina: (2006)

Drug-membrane interactions analysis, drug distribution, modeling /
mā: Seydel, J. K. (Joachim Karl)
I whakaputaina: (2002)

Non-ionizing radiation.
I whakaputaina: (2002)

A review of the draft report of the NCI-CDC Working Group to revise the 1985 radioepidemiological tables
I whakaputaina: (2000)

Smokeless tobacco and some tobacco-specific N-nitrosamines
I whakaputaina: (2007)

Risk modeling, assessment, and management
mā: Haimes, Yacov Y.
I whakaputaina: (2004)

Risk modeling, assessment, and management /
mā: Haimes, Yacov Y.
I whakaputaina: (2016)

Skin sensitization in chemical risk assessment
I whakaputaina: (2008)

Principles of clinical pharmacology
I whakaputaina: (2007)

Nonclinical safety assessment a guide to international pharmaceutical regulations /
I whakaputaina: (2013)

Risk assessment : a practical guide to assessing operational risks /
mā: Popov, Georgi (Engineer), me ētahi atu.
I whakaputaina: (2016)

In vivo models for drug discovery /
I whakaputaina: (2014)

Oral bioavailability basic principles, advanced concepts, and applications /
I whakaputaina: (2011)

A mathematical approach to multilevel, multiscale health interventions pharmaceutical industry decline and policy response /
mā: Wallace, Rodrick
I whakaputaina: (2013)

National risk assessments : a cross country perspective.
I whakaputaina: (2017)

Chemical risk analysis a practical handbook /
mā: Martel, Bernard
I whakaputaina: (2004)

Framework for chemical risk management under REACH regulatory decision-making /
mā: Erler, Steffen
I whakaputaina: (2009)

Drug development principles, methodology and emerging challenges /
I whakaputaina: (2013)

Physiologically-based pharmacokinetic (PBPK) modeling and simulations principles, methods, and applications in the pharmaceutical industry /
mā: Peters, Sheila Annie
I whakaputaina: (2011)

Issues in risk assessment
I whakaputaina: (1993)

Post-genomic approaches in drug and vaccine development /
I whakaputaina: (2015)

Modeling risk applying Monte Carlo simulation, real options analysis, forecasting, and optimization techniques /
mā: Mun, Johnathan
I whakaputaina: (2010)

Risk and responsibility
mā: Leiss, William, 1939-
I whakaputaina: (1994)

Retrometabolic drug design and targeting
mā: Bodor, Nicholas
I whakaputaina: (2012)

Biological drug products : development and strategies /
I whakaputaina: (2013)

Statistical thinking for non-statisticians in drug regulation /
mā: Kay, R. (Richard), 1949-
I whakaputaina: (2015)

Human drug targets : a compendium for pharmaceutical discovery /
mā: Zanders, Edward D.
I whakaputaina: (2016)

Risk assessment for chemicals in drinking water
I whakaputaina: (2008)

Virtual ADMET assessment in target selection and maturation
I whakaputaina: (2006)

Alternative ecological risk assessment : an innovative approach to understanding ecological assessments for contaminated sites /
mā: Tannenbaum, Lawrence
I whakaputaina: (2014)

Lead generation approaches in drug discovery
I whakaputaina: (2010)

Target validation in drug discovery
I whakaputaina: (2006)

Pharmacokinetics and metabolism in drug design
I whakaputaina: (2012)

Evaluation of drug candidates for preclinical development pharmacokinetics, metabolism, pharmaceutics, and toxicology /
I whakaputaina: (2010)

Drug metabolism prediction /
I whakaputaina: (2014)

Review of the Prince William Sound, Alaska, risk assessment study
I whakaputaina: (1998)